Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Diseases

Free Subscription 22.04.2019 3 AJR Am J Roentgenol 4 Biochem Biophys Res Commun 2 BMC Cancer 4 BMC Gastroenterol 1 Br J Surg 1 Cancer 2 Dig Dis Sci 2 Eur Radiol 2 Gastroenterology 5 Hepatology 1 Int J Cancer 1 J Gastroenterol Hepatol 1 J Hepatol 1 J Pediatr 1 Lancet 1 N Engl J Med 3 PLoS One 1 Radiology 1 Semin Liver Dis 6 Transplant Proc 4 Transplantation

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. LIMA PH, Fan B, Berube J, Cerny M, et al
   Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.
   AJR Am J Roentgenol. 2019 Apr 17:1-9. doi: 10.2214/AJR.18.20341.
   PubMed     Text format     Abstract available
   
   
2. FURLAN A, Brancatelli G, Burgio MD, Grazioli L, et al
   Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
   AJR Am J Roentgenol. 2018 Jan 11:1-5. doi: 10.2214/AJR.17.18867.
   PubMed     Text format     Abstract available
   
   
3. NAKAI Y, Gonoi W, Hagiwara A, Nishioka Y, et al
   MRI Detection of Intratumoral Fat in Colorectal Liver Metastases After Preoperative Chemotherapy.
   AJR Am J Roentgenol. 2018 Apr 9:W1-W9. doi: 10.2214/AJR.17.18814.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

4. JI D, Wang Y, Sun B, Yang J, et al
   Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
   Biochem Biophys Res Commun. 2019 Apr 11. pii: S0006-291X(19)30634.
   PubMed     Text format     Abstract available
   
   
5. LONG Q, Zou X, Song Y, Duan Z, et al
   PFKFB3/HIF-1alpha feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells.
   Biochem Biophys Res Commun. 2019 Apr 10. pii: S0006-291X(19)30498.
   PubMed     Text format     Abstract available
   
   
6. KIM MB, Bae M, Hu S, Kang H, et al
   Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cells.
   Biochem Biophys Res Commun. 2019 Apr 11. pii: S0006-291X(19)30680.
   PubMed     Text format     Abstract available
   
   
7. GUO J, Duan H, Li Y, Yang L, et al
   A novel circular RNA circ-ZNF652 promotes hepatocellular carcinoma metastasis through inducing snail-mediated epithelial-mesenchymal transition by sponging miR-203/miR-502-5p.
   Biochem Biophys Res Commun. 2019 Apr 15. pii: S0006-291X(19)30621.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. PARK Y, Kim BK, Park JY, Kim DY, et al
   Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma.
   BMC Cancer. 2019;19:363.
   PubMed     Text format     Abstract available
   
   
9. HUANG K, Dong Z, Cai H, Huang M, et al
   Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
   BMC Cancer. 2019;19:364.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

10. TORGERSEN J, So-Armah K, Freiberg MS, Goetz MB, et al
    Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.
    BMC Gastroenterol. 2019;19:52.
    PubMed     Text format     Abstract available
    
    
11. PU K, Wang Y, Bai S, Wei H, et al
    Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    BMC Gastroenterol. 2019;19:51.
    PubMed     Text format     Abstract available
    
    
12. SUN G, Jackson CV, Zimmerman K, Zhang LK, et al
    The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    BMC Gastroenterol. 2019;19:41.
    PubMed     Text format     Abstract available
    
    
13. FITRIAKUSUMAH Y, Lesmana CRA, Bastian WP, Jasirwan COM, et al
    The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    BMC Gastroenterol. 2019;19:43.
    PubMed     Text format     Abstract available
    
    

    
    Br J Surg

14. TAKEMURA N, Aoki T, Hasegawa K, Kaneko J, et al
    Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
    Br J Surg. 2019 Apr 16. doi: 10.1002/bjs.11153.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

15. SHIELS MS, Engels EA, Yanik EL, McGlynn KA, et al
    Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
    Cancer. 2019 Apr 12. doi: 10.1002/cncr.32129.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

16. NAKATAKE R, Hishikawa H, Kotsuka M, Ishizaki M, et al
    The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05622.
    PubMed     Text format     Abstract available
    
    
17. KARAGIANNAKIS DS, Voulgaris T, Koureta E, Chloupi E, et al
    Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05616.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

18. LEBERT P, Adens-Fauquembergue M, Azahaf M, Gnemmi V, et al
    MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06210.
    PubMed     Text format     Abstract available
    
    
19. HONG SB, Lee NK, Kim S, Seo HI, et al
    Modified CAIPIRINHA-VIBE without view-sharing on gadoxetic acid-enhanced multi-arterial phase MR imaging for diagnosing hepatocellular carcinoma: comparison with the CAIPIRINHA-Dixon-TWIST-VIBE.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06095.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

20. KIM SB, Kim JW, Choi JH
    A rare cause of multiple hepatic masses.
    Gastroenterology. 2019 Apr 14. pii: S0016-5085(19)35696.
    PubMed     Text format    
    
    
21. O'LEARY JG, Greenberg CS, Patton HM, Caldwell SH, et al
    Coagulation in Cirrhosis.
    Gastroenterology. 2019 Apr 12. pii: S0016-5085(19)35694.
    PubMed     Text format    
    
    

    
    Hepatology

22. LIU R, Li X, Zhu W, Wang Y, et al
    Cholangiocyte-derived exosomal LncRNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.
    Hepatology. 2019 Apr 15. doi: 10.1002/hep.30662.
    PubMed     Text format     Abstract available
    
    
23. DO A, Kuszewski EJ, Mehal WZ
    Incorporating Weight Loss Medications into Hepatology Practice for Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30658.
    PubMed     Text format     Abstract available
    
    
24. YANG HD, Kim HS, Kim SY, Na MJ, et al
    HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30657.
    PubMed     Text format     Abstract available
    
    
25. SANYAL AJ, Harrison SA, Ratziu V, Abdelmalek MF, et al
    The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30664.
    PubMed     Text format     Abstract available
    
    
26. HAGE C, Hoves S, Strauss L, Bissinger S, et al
    Sorafenib Induces Pyroptosis in Macrophages and Triggers NK Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30666.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

27. IIDA N, Mizukoshi E, Yamashita T, Terashima T, et al
    Overuse of anti-anaerobic drug is associated with poor post-chemotherapy prognosis of patients with hepatocellular carcinoma.
    Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32339.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

28. XIANG Q, Zhou D, He X, Fan J, et al
    The zinc finger protein GATA4 induces MET and cellular senescence through the NF-kappaB pathway in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Apr 17. doi: 10.1111/jgh.14684.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

29. ALEKSIEVA N, Forbes SJ
    Biliary-derived hepatocytes in chronic liver injury: Bringing new troops to the battlefield?
    J Hepatol. 2019 Apr 10. pii: S0168-8278(19)30185.
    PubMed     Text format    
    
    

    
    J Pediatr

30. ALMAAS R, Haflidadottir S, Kaldestad RH, Matthews IL, et al
    Asthma, Eczema, and Food Allergy in Children Following Liver Transplantation.
    J Pediatr. 2018 Sep 27. pii: S0022-3476(18)31224.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

31. CORNEC-LE GALL E, Alam A, Perrone RD
    Autosomal dominant polycystic kidney disease.
    Lancet. 2019;393:919-935.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

32. JONES DE, Hegade VS
    Bezafibrate in Primary Biliary Cholangitis.
    N Engl J Med. 2018;379:984.
    PubMed     Text format    
    
    

    
    PLoS One

33. DEGROAT AR, Fleming CK, Dunlay SM, Hagood KL, et al
    The sex specific effect of alcohol consumption on circulating levels of CTRP3.
    PLoS One. 2018;13:e0207011.
    PubMed     Text format     Abstract available
    
    
34. DAHER S, Lev Cohen N, Massarwa M, Mahamid M, et al
    Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0207479.
    PubMed     Text format     Abstract available
    
    
35. MEHTA R, Shaw G, Masschelin P, Felix S, et al
    Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    PLoS One. 2018;13:e0199294.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

36. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019 Apr 16:182587. doi: 10.1148/radiol.2019182587.
    PubMed     Text format     Abstract available
    
    

    
    Semin Liver Dis

37. PATTEN DA, Shepherd EL, Weston C, Shetty S, et al
    Erratum: Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.
    Semin Liver Dis. 2019 Apr 16. doi: 10.1055/s-0039-1688409.
    PubMed     Text format    
    
    

    
    Transplant Proc

38. MATSUURA K, Takami T, Maeda M, Hisanaga T, et al
    Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis.
    Transplant Proc. 2019;51:925-935.
    PubMed     Text format     Abstract available
    
    
39. SHANMUGAM N, Valamparampil JJ, Vij M, Reddy MS, et al
    Ischemic Cholangiopathy: Insight From an Explant Liver Allograft Affected by Severe Post-transplant Hypoxemia Due to Hepatopulmonary Syndrome: A Case Report.
    Transplant Proc. 2019;51:1002-1005.
    PubMed     Text format     Abstract available
    
    
40. KIM D, Shin BS, Song I, Han S, et al
    Relationship Between Intraoperative Bispectral Index and Consciousness Recovery in Patients With Hepatic Encephalopathy Undergoing Liver Transplant: A Retrospective Analysis.
    Transplant Proc. 2019;51:798-804.
    PubMed     Text format     Abstract available
    
    
41. ZHAO J, Mao J, Li W
    Association of Tumor Grade With Long-Term Survival in Patients With Hepatocellular Carcinoma After Liver Transplantation.
    Transplant Proc. 2019;51:813-819.
    PubMed     Text format     Abstract available
    
    
42. WAN Z, Wang X, Zhang X, Zhang X, et al
    Intrasplenic Transplantation of Cytotoxic T-Lymphocyte Associated Protein 4-Fas Ligand--Modified Hepatic Oval Cells for Acute Liver Injury in Rats.
    Transplant Proc. 2019;51:942-950.
    PubMed     Text format     Abstract available
    
    
43. MA Z, Qian P, Shen R, Hu B, et al
    Pharmacological Signatures of the Exenatide Nanoparticles Against Hepatic Ischemia/Reperfusion-induced Pancreatic Injury.
    Transplant Proc. 2019;51:960-965.
    PubMed     Text format     Abstract available
    
    

    
    Transplantation

44. DURAND F, Francoz C, Asrani SK, Khemichian S, et al
    Acute Kidney Injury after Liver Transplantation.
    Transplantation. 2018 May 29. doi: 10.1097/TP.0000000000002305.
    PubMed     Text format     Abstract available
    
    
45. ALLEN AM, Heimbach JK, Larson JJ, Mara KC, et al
    Reduced access to liver transplantation in women: role of height, MELD exception scores and renal function underestimation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002196.
    PubMed     Text format     Abstract available
    
    
46. LIU Y, Lu T, Zhang C, Xue Z, et al
    Pituitary Adenylate Cyclase-Activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia/Reperfusion Injury.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002742.
    PubMed     Text format     Abstract available
    
    
47. HONDA M, Sugawara Y, Kadohisa M, Shimata K, et al
    Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002197.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: